Related Experiment Video
Updated: Oct 21, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Is kidney a new organ target in patients with obstructive sleep apnea? Research priorities in a rapidly evolving
Athanasios Voulgaris1, Maria R Bonsignore2, Sophia Schiza3
1MSc Programme in Sleep Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece; Department of Respiratory Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Abstract:
The bidirectional relationship between sleep disordered breathing and chronic kidney disease (CKD) has recently gained a lot of interest. Several lines of evidence suggest the high prevalence of coexistent obstructive sleep apnea (OSA) in patients with CKD and end-stage renal disease (ESRD). In addition, OSA seems to result in loss of kidney function in some patients, especially in those with cardio-metabolic comorbidities. Treatment of CKD/ESRD and OSA can alter the natural history of each other; still better phenotyping with selection of appropriate treatment approaches is urgently needed. The aim of this narrative review is to provide an update of recent studies on epidemiological associations, pathophysiological interactions, and management of patients with OSA and CKD or ESRD.
Insights
Obstructive sleep apnea (OSA) is common in chronic kidney disease (CKD) and may worsen kidney function. Treating both conditions is crucial, but better patient selection for therapies is needed.
Area of Science:
- Nephrology
- Pulmonology
- Sleep Medicine
Background:
- Sleep disordered breathing (SDB) and chronic kidney disease (CKD) share a complex bidirectional relationship.
- Obstructive sleep apnea (OSA) is highly prevalent in patients with CKD and end-stage renal disease (ESRD).
- OSA may contribute to kidney function decline, particularly in patients with cardio-metabolic conditions.
Purpose of the Study:
- To review recent research on the epidemiological associations between OSA and CKD/ESRD.
- To explore the pathophysiological mechanisms linking OSA and kidney disease.
- To update knowledge on the management strategies for patients with coexisting OSA and CKD/ESRD.
Main Methods:
- Narrative review of recent scientific literature.
- Synthesis of epidemiological data.
- Analysis of pathophysiological interactions.
- Evaluation of current management approaches.
Main Results:
- High co-occurrence of OSA in CKD/ESRD populations.
- Evidence suggesting OSA exacerbates kidney disease progression.
- Potential for mutual treatment effects on disease trajectories.
- Need for improved phenotyping and tailored treatment.
Conclusions:
- The interplay between OSA and CKD/ESRD is significant and warrants clinical attention.
- Effective management requires a comprehensive understanding of their relationship.
- Further research is needed to optimize treatment strategies through precise patient stratification.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Kidney Transplant I: Introduction
Heart Failure VI: Adjunct Therapies
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care

